Competitive NMDA receptor antagonists do not block cholinergic kindling with carbachol

Epilepsy Research

Volumn 24, Issue 1, 1996, Pages 9-18

  Saucier, D ^a   Cain, D P ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Epileptogenesis; Excitatory amino acid

Indexed keywords

2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; CARBACHOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; HIPPOCAMPUS; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030003233     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-1211(95)00106-9     Document Type: Article

References (45)

1. Arnold, P.S., Racine, R.J. and Wise, R.A., Effects of atropine, reserpine. 6-hydroxydopamine and handling on seizure development in the rat, Exp. Neurol., 40 (1973) 457-470.
2. Burchfiel, J.L., Duchowny, M.S. and Duffy, F.H., Neuronal supersensitivity to acetylcholine induced by kindling in the rat hippocampus, Science, 204 (1979) 1096-1098.
3. Cain, D.P., Bidirectional transfer of electrical and carbachol kindling, Brain Res., 260 (1983) 135-138.
4. Cain, D.P., Excitatory neurotransmitters in kindling: excitatory amino acid, cholinergic, and opiate mechanisms, Neurosci. Biobehav. Rev., 13 (1989) 269-276.
5. Cain, D.P., Boon, F. and Corcoran, M.E., Involvement of multiple opiate receptors in opioid kindling, Brain Res., 517 (1990) 236-244. 1990.
6. Cain, D.P., Boon, F. and Hargreaves, E.L., Evidence for different pharmacological contributions to long-term potentiation and to kindling and kindling-induced potentiation: role of NMDA and urethane-sensitive mechanisms, Exp. Neurol., 116 (1992) 330-338.
7. Cain, D.P., Desborough, K.A. and McKitrick, D.J., Retardation of amygdala kindling by antagonism of NMD-aspartate and muscarinic cholinergic receptors: evidence for the summation of excitatory mechanisms in kindling, Exp. Neurol., 100 (1988) 179-187.
8. Croucher, M.J. and Bradford, H.F., Kindling of full limbic seizures by repeated microinjections of excitatory amino acids into the rat amygdala, Brain Res., 501 (1989) 58-65.
9. Croucher, M.J. and Bradford, H.F., NMDA receptor blockade inhibits glutamate-induced kindling of the rat amygdala, Brain Res., 506 (1990) 349-352.
10. Croucher, M.J., Collins, J.F. and Meldrum, B.S., Anticonvulsant action of excitatory amino acids, Science, 218 (1982) 899-901.
11. Dennison, Z. and Cain, D.P., Retardation of amygdaloid kindling in the rat by the excitatory amino acid antagonist kynurenic acid, Synapse, 4 (1989) 171-173.
12. Dingledine, R., McBain, C.J. and McNamara, J.O., Excitatory amino acid receptors in epilepsy, Trends. Pharmacol. Sci. Spec. Rep., (1990) 49-53.
13. Ferkany, J.W., Hamilton, G.S., Patch, R.J., Huang, Z., Borosky, S.A., Bednar, D.L., Jones, B.E., Zubrowski, R., Willetts, J. and Karbon, E.W., Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5(1,2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist, J. Pharmacol. Exp. Ther.. 264 (1993) 256-264.
14. Fukuda, H., Tatsuya, T., Kaijima, M., Nakai, H. and Yonemasu, Y., Quisqualic acid-induced hippocampal seizures in unanesthetized cats, Neurosci. Lett., 59 (1985) 53-59.
15. Gilbert, M.E., The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures, Brain Res., 463 (1988) 90-99.
16. Gilbert, M.E., The NMDA antagonist MK-801 suppresses behavioral seizures, augments afterdischarges, but does not block development of perforant path kindling, Epilepsy Res., 17 (1994) 145-156.
17. Gilbert, M.E. and Mack, C.M., The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat, Brain Res., 519 (1990) 89-96.
18. Herron, C.E., Williamson, R. and Collingridge, G.L., A selective N-methyl-D-aspartate antagonist depresses epileptiform activity in rat hippocampal slices, Neurosci. Lett., 61 (1985) 255-260.
19. Holmes, K.H., Bilkey, D.K., Laverty, R. and Goddard, G.V., The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures, Brain Res., 506 (1990) 227-235.
20. Loscher, W. and Honack, D., Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine, J. Pharmacol. Exp. Ther., 256 (1991) 432-440.
21. Martin, D., McNamara, J.O. and Nadler, J.V., Kindling enhances sensitivity of CA3 hippocampal pyramidal cells to NMDA, J. Neurosci., 12 (1992) 1928-1935.
22. McNamara, J.O., Morrisett, R. and Nadler, J.V., Recent advances in understanding mechanisms of the kindling model. In: P. Chavel and A.V. Delgado-Escueta (Eds.), Advances in Neurology, Vol. 57, Raven Press, New York, NY, 1992, pp. 555-560.
23. McNamara, J.O., Russell, R.D., Rigsbee, L. and Bonhaus, D.W., Anticonvulsant and antiepileptiform actions of MK-801 in kindling and electroshock models, Neuropharmacology, 27 (1988) 563-568.
24. Millan, M.H., Meldrum, B.S. and Faingold, C., Induction of audiogenic seizure susceptibility by focal infusion of excitant amino acid or bicuculline into the inferior colliculus of normal rats, Exp. Neurol., 91 (1986) 634-639.
25. Monaghan, D.T., Anatomical organization and apparent heterogeneity of NMDA receptors. In: A.P. Kozikowski (Ed.), Neurobiology of the NMDA Receptor: From Chemistry to the Clinic, VCH Publishers, New York, NY, 1991, pp. 149-171.
26. Monyer, H., Burnashev, N., Laurie, D., Sakmann, B. and Seeberg, P., Development and regional expression in the rat brain and functional properties of four NMDA receptors, Neuron, 12 (1994) 529-540.
27. Mori, N. and Wada, J., Bidirectional transfer of kindling induced between excitatory amino acids and electrical stimulation, Brain Res., 425 (1987) 45-48.
28. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates (2nd Ed.), Academic Press, Sydney, Australia, 1986.
29. Pellegrino, L.J., Pellegrino, A.S. and Cushman, A.J., A Stereotaxic Atlas of the Rat Brain (2nd Ed.), Plenum Press, New York, NY, 1979.
30. Peterson, D.W., Collins, J.F. and Bradford, H.F., The kindled amygdala model of epilepsy: anticonvulsant action of amino acid antagonists, Brain Res., 275 (1983) 169-172.
31. Peterson, D.W., Collins, J.F. and Bradford, H.F., Anticonvulsant action of amino acid antagonists against kindled hippocampal seizures, Brain Res., 311 (1984) 176-180.
32. Racine, R.J., Modification of seizure activity by electrical stimulation. II. Motor seizure, Electroenceph. Clin. Neurophysiol., 32 (1972) 281-294.
33. Sato, K., Morimoto, K. and Okamoto, M., Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy, Brain Res., 463 (1988) 12-20.
34. Saucier, D. and Cain, D.P., Spatial learning without NMDA-dependent long term potentiation, Nature, 378 (1995), 186-188.
35. Saucier, D., Hargreaves, E.L., Boon, F., Vanderwolf, C.H. and Cain, D.P., Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: nonspatial pretraining eliminates spatial learning deficits, Behav. Neurosci., in press.
36. Simalowski, A., Excitatory effect of intrahippocampal injection of glutamic acid on rabbit EEG, J. Neural Trans., 58 (1983) 205-211.
37. Stasheff, S.F., Anderson, W.W., Clark, S. and Wilson, W.A., NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model, Science, 245 (1989) 648-651.
38. Stelzer, A., Slater, N.T., Galvan, M. and Bruggencate, G., N-methyl-D-aspartate receptors and hippocampal kindling. In: T.P. Hicks et al. (Eds.), Excitatory Amino Acid Transmission, Alan R. Liss, New York, NY, 1987, pp. 71-74.
39. Trommer, B.L. and Pasternak, J.F., NMDA receptor antagonists inhibit kindling epileptogenesis and seizure expression in developing rats, Dev. Brain Res., 53 (1990) 248-252.
40. Vosu, H. and Wise, R.A., Cholinergic seizure kindling in the rat: comparison of caudate, amygdala and hippocampus, Behav. Biol., 13 (1975) 491-495.
41. Wasterlain, C.G. and Jonec, V., Cholinergic kindling of the amygdala requires the activation of muscarinic receptors, Exp. Neurol., 73 (1981) 595-599.
42. Wasterlain, C.G. and Jonec, V., Chemical kindling by muscarinic amygdaloid stimulation in the rat. Brain Res., 271 (1983) 311-323.
43. Westerberg, V. and Corcoran, M.E., Antagonism of central but not peripheral Cholinergic receptors retards amygdala kindling in rats, Exp. Neurol., 95 (1987) 1994-206.
44. Willetts, J., Clissold, D.B., Hartman, T.L., Brandsgaard, R.R., Hamilton, G.S. and Ferkany, J.W., Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist, J. Pharmacol. Exp. Ther., 265 (1993) 1055-1062.
45. Young, N.A., Lewis, S.S., Vajda, F. and Beart, P., Effects of NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat, Exp. Neurol., 103 (1989) 199-202.